Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Long-Term Investments: 2020-2025

Historic Long-Term Investments for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $12.0 million.

  • Caribou Biosciences' Long-Term Investments fell 77.38% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year decrease of 77.38%. This contributed to the annual value of $39.8 million for FY2024, which is 8.55% down from last year.
  • Latest data reveals that Caribou Biosciences reported Long-Term Investments of $12.0 million as of Q3 2025, which was up 8,955.30% from $132,000 recorded in Q2 2025.
  • Caribou Biosciences' 5-year Long-Term Investments high stood at $69.4 million for Q4 2022, and its period low was $132,000 during Q2 2025.
  • Over the past 3 years, Caribou Biosciences' median Long-Term Investments value was $43.6 million (recorded in 2023), while the average stood at $37.6 million.
  • Per our database at Business Quant, Caribou Biosciences' Long-Term Investments soared by 545.44% in 2022 and then plummeted by 99.74% in 2025.
  • Over the past 5 years, Caribou Biosciences' Long-Term Investments (Quarterly) stood at $37.7 million in 2021, then soared by 84.13% to $69.4 million in 2022, then plummeted by 37.18% to $43.6 million in 2023, then dropped by 8.55% to $39.8 million in 2024, then slumped by 77.38% to $12.0 million in 2025.
  • Its Long-Term Investments stands at $12.0 million for Q3 2025, versus $132,000 for Q2 2025 and $9.3 million for Q1 2025.